HealthWise KnowledgeBase
Gonadotropin-Releasing Hormone Analogue (GnRH-A) Therapy
Examples
gonadotropin-releasing hormone analogue (GnRH-a)
| Brand Name | Generic Name | Chemical Name |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
- Leuprolide is injected into a muscle (intramuscularly) once a month. It is also available in a dose that lasts for 3 months.
- Nafarelin is sprayed into the nose (intranasally) twice a day.
- Goserelin (3.6 mg pellet) is injected under the skin of the abdomen (subcutaneously) once every 28 days. The pellet is gradually absorbed by the body.
Gonadotropin-releasing hormone analogue (GnRH-a) therapy is approved for the treatment of endometriosis and uterine fibroids. A GnRH-a is rarely used for dysfunctional uterine bleeding.
To avoid long-term side effects, GnRH-a therapy is usually taken for only 3 to 6 months.
| By: | Reference Healthwise Staff | Last Revised: May 14, 2012 |
| Medical Review: | Reference Sarah Marshall, MD - Family Medicine
Reference Divya Gupta, MD - Obstetrics and Gynecology, Gynecologic Oncology |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
